RxDoctor Payments Data

Clara Easterlin, PA

Medical · Nashville, TNNPI 1871364018

Payments from drug & device makers

$2,151in general payments, 2019–2025

Across 90 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$712
  • Regeneron Healthcare Solutions, Inc.$350
  • UCB, Inc.$331
  • Novartis$212
  • AbbVie$160
  • Sanofi$145
  • plus $241 from 6 others

What the payments were for

  • Food & beverage$1,84886%
  • Education$30314%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)26$712
Regeneron Healthcare Solutions, Inc.15$350
UCB, Inc.14$331
Novartis14$212
AbbVie8$160
Sanofi2$145
Lilly USA, LLC4$78
Incyte Corporation3$71
Cipher Pharmaceuticals US LLC1$39
Amgen1$21
Arcutis Biotherapeutics, Inc.1$18
Galderma Laboratories, L.p.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,151 in reported general payments places this provider in the 70th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$12,456
Medicare patients
48
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate27$1,460
Ketoconazole30$417
Hydroxyzine Hcl19$330
Triamcinolone Acetonide13$143

Paid to pharmacies, not to this prescriber.

Other medical in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →